Bath & Body Works, Inc. USDC – Southern District of Ohio January 21, 2026 CLASS PERIOD: June 4, 2024 – november 19, 2025 Deadline: March 16, 2026 Please complete the form below to contact Kaplan Fox regarding the Bath & Body Works Investigation: Join a Case First Name * Last Name * Email Address * Phone Number * Ticker Symbol Or Company Name * Please Insert Your Estimation Of Losses In USD * Are you a current or former employee of the company mentioned having traded above? * Yes No Captcha Submit If you are human, leave this field blank. Principle Contacts Pamela MayerPMayer@kaplanfox.comLaurence D. KingLKing@kaplanfox.com Kaplan Fox Alerts Investors of Bath & Body Works, Inc. (BBWI) to a Securities Class Action Deadline on March 16, 2026 Kaplan Fox & Kilsheimer LLP informs investors that a class action lawsuit has been filed against Bath & Body Works, Inc. (“Bath & Body Works” or the “Company”) (NYSE: BBWI) on behalf of investors that purchased or otherwise acquired Bath & Body Works securities between June 4, 2024 and November 19, 2025 (the “Class Period”). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you purchased Bath & Body Works securities during the Class Period and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003. DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than March 16, 2026 to serve as a lead plaintiff for the purported class. If you have losses, we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery. On November 20, 2025, before the market opened, Bath & Body Works released its third quarter 2025 financial results. According to the complaint, the Company reported that “revenue declined 1% year over year, missing [the] Company’s guidance of 1-3% growth for the quarter” and that “[n]et income also declined, falling 26% to $77 million.” The complaint further alleges that Bath & Body Works “slash[ed] full year guidance for net sales from a previously positive 1.5%-2.7% to a negative ‘high single digits.”’ Following this news, the price of Bath & Body Works shares fell $5.22 per share, or 24.8%, to close at $15.82 per share on November 20, 2025. The complaint alleges, among other things, that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that (i) Bath & Body Works’ strategy of pursuing “adjacencies, collaborations and promotions” was not growing the customer base and/or delivering the level of growth in net sales touted; (ii) as Bath & Body Works’ strategy of “adjacencies, collaborations and promotions” faltered, it relied on brand collaborations “to carry quarters” and obfuscate otherwise weak underlying financial results; (iii) as a result, Bath & Body Works was unlikely to meet its own previously issued financial guidance; and (iv) as a result of the foregoing, defendants’ positive statements about Bath & Body Works’ business, operations, and prospects were materially misleading and/or lacked a reasonable basis. WHY CONTACT KAPLAN FOX Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this investigation, please contact: CONTACT: Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003pmayer@kaplanfox.com Laurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1501Oakland, California 94612(415) 772-4704lking@kaplanfox.com The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client. Any information you submit will be maintained as confidential. If Kaplan Fox, in its sole discretion, believes that you might be an appropriate client, Kaplan Fox will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases. Connect with Kaplan Fox. Receive a complimentary case review now. Contact Us Bath & Body Works, Inc. See the Case Gibraltar Industries, Inc. See the Case Wealthfront Corporation See the Case Chagee Holdings Limited See the Case AeroVironment, Inc. See the Case Aquestive Therapeutics, Inc. See the Case Snowflake Inc. See the Case Jefferies Financial Group See the Case Ardent Health, Inc. See the Case CoreWeave, Inc. See the Case Beta Bionics, Inc. See the Case Varonis Systems, Inc. See the Case
